How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer compared with platinum-based chemotherapy: a plain language summary of patient-reported outcomes from the EV-302 study.
APA
Gupta S, Loriot Y, et al. (2026). How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer compared with platinum-based chemotherapy: a plain language summary of patient-reported outcomes from the EV-302 study.. Future oncology (London, England), 22(9), 1015-1029. https://doi.org/10.1080/14796694.2026.2645984
MLA
Gupta S, et al.. "How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer compared with platinum-based chemotherapy: a plain language summary of patient-reported outcomes from the EV-302 study.." Future oncology (London, England), vol. 22, no. 9, 2026, pp. 1015-1029.
PMID
41925239
같은 제1저자의 인용 많은 논문 (5)
- 'Rosebud' inset of DIEP flap in delayed breast reconstruction for consistent projection, lateral flow, and ptosis.
- Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial).
- Imaging of peritoneal surface malignancies: diagnosis and clinical implications.
- Influence of Peptide-Based Chelator Sequences on HER2-Targeting Radiopeptide.
- Personal Strategies for DIEP Flap Breast Reconstruction in Patients with Prior Abdominal Surgery and Hernia Repairs.